Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | January 2022

In the ordinary rebalance the following composition will be implemented effective open 10.01.2022:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
AMGEN INC
ANTHEM INC
BAXTER INTL.
BECTON DICKINSON AND CO
BIO-RAD LABORATORIES INC
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
CHEMED CORP
CHR HANSEN HOLDING AS
COLOPLAST AS CLASS B
COOPER COMPANIES INC
DANAHER CORP
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
FRESENIUS SE & CO KGAA
GILEAD SCIENCES INC
HOLOGIC INC
HUMANA INC
INTUITIVE SURGICAL INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
LONZA GROUP AG
MASIMO CORPORATION
MEDTRONIC PLC
MERCK KGAA
METTLER-TOLEDO INTL
NOVARTIS AG
NOVOZYMES AS CLASS B
ORION OYJ CLASS B
PERKINELMER INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
RESMED INC
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
STERIS PLC
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
WATERS CORP
WEST PHARMACEUTICAL SERVICES INC
ZOETIS INC